In Vitro Maturation (IVM) Gains Momentum in Australia, Mexico, and Vietnam

Stork Club Team -

For individuals and couples seeking fertility treatments, a less invasive and hormone-free alternative to in vitro fertilization (IVF) is emerging: in vitro maturation (IVM). Unlike IVF, which requires hormonal stimulation to mature eggs before retrieval, IVM involves collecting immature eggs and maturing them in a lab, reducing the risks associated with hormone injections.

IVM’s Success Rates Are Improving

Historically, IVM has had lower success rates compared to IVF, but new advancements are changing the landscape. Researchers have found that for certain patients, particularly those with polycystic ovary syndrome (PCOS) and hyper-responders, IVM can achieve live birth rates of 40% or higher per cycle—comparable to standard IVF success rates. In Vietnam, clinical trials report 35% success rates with IVM, making it an increasingly viable option for fertility patients worldwide.

With the potential to lower costs and reduce the physical burden of fertility treatments, IVM is gaining traction in countries like Australia, Mexico, and Vietnam, offering a promising path for many seeking alternative fertility solutions.

Expanding Access to Fertility Treatments Globally

As validated fertility innovations like IVM continue to improve, it’s crucial for employers to ensure their employees have access to evidence-based, high-quality fertility care no matter where they are.

Stork Club provides family-building benefits in over 100 countries outside of the U.S., supporting new, clinically validated treatments that help employees achieve better outcomes while lowering the cost of care. Our global approach ensures that individuals have access to cutting-edge reproductive care that meets the highest medical standards, empowering them to make informed choices about their fertility journey.

The Future of Family-Building Benefits

As fertility treatments evolve, employers have a unique opportunity to expand their benefits strategies and include innovative solutions that improve employee outcomes while reducing costs. In vitro maturation is just one example of how modern advancements are shaping the future of reproductive healthcare.

To learn how Stork Club can support your workforce with global, research-backed family-building benefits, contact our team for a live demo.

Sources

  • Reproductive Biology and Endocrinology. (2024). Clinical pregnancy rate per embryo transfer in IVM vs. IVF.
  • Frontiers in Endocrinology. (2024). Live birth rates in IVM with ICSI compared to standard ICSI cycles.
  • MDPI. (2024). Ongoing pregnancy rates in IVM cycles.